The Chemours Company (CC)

The Chemours Company Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	5,841	6,027	6,794	6,345	4,969	5,526
Revenue Growth (YoY)	-11.04%	-11.29%	7.08%	27.69%	-10.08%	-16.75%
Cost of Revenue	4,617	4,721	5,178	4,964	3,902	4,463
Gross Profit	1,224	1,306	1,616	1,381	1,067	1,063
Selling, General & Admin	1,309	1,290	710	592	527	548
Research & Development	110	108	118	107	93	80
Other Operating Expenses	141	153	16	6	80	87
Operating Expenses	1,560	1,551	844	705	700	715
Operating Income	-336	-245	772	676	367	348
Interest Expense / Income	229	208	163	185	210	208
Other Expense / Income	-141	-134	-132	-185	-22	264
Pretax Income	-424	-319	741	676	179	-124
Income Tax	-94	-81	163	68	-40	-72
Net Income	-330	-238	578	608	219	-52
Net Income Growth	-	-	-4.93%	177.63%	-	-
Shares Outstanding (Basic)	149	148	151	163	164	164
Shares Change	0.31%	-1.64%	-7.39%	-0.93%	0.61%	-4.43%
EPS (Basic)	-2.22	-1.60	3.72	3.69	1.33	-0.32
EPS (Diluted)	-2.23	-1.60	3.65	3.60	1.32	-0.32
EPS Growth	-	-	1.39%	172.73%	-	-
Free Cash Flow	4	186	448	537	540	169
Free Cash Flow Per Share	0.03	1.25	2.97	3.29	3.28	1.03
Dividend Per Share	1.000	1.000	1.000	1.000	1.000	1.000
Dividend Growth	0%	0%	0%	0%	0%	19.05%
Gross Margin	20.96%	21.67%	23.79%	21.77%	21.47%	19.24%
Operating Margin	-5.75%	-4.07%	11.36%	10.65%	7.39%	6.30%
Profit Margin	-5.65%	-3.95%	8.51%	9.58%	4.41%	-0.94%
Free Cash Flow Margin	0.07%	3.09%	6.59%	8.46%	10.87%	3.06%
Effective Tax Rate	-	-	22.00%	10.06%	-22.35%	-
EBITDA	104	196	1,195	1,178	709	395
EBITDA Margin	1.78%	3.25%	17.59%	18.57%	14.27%	7.15%
Depreciation & Amortization	299	307	291	317	320	311
EBIT	-195	-111	904	861	389	84
EBIT Margin	-3.34%	-1.84%	13.31%	13.57%	7.83%	1.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).